Search

Search results

448 results found

Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retina

Publication: Journal Article

Notomi, Shoji, Kenji Ishihara, Nikolaos Efstathiou, Jong-Jer Lee, Toshio Hisatomi, Takashi Tachibana, Eleni Konstantinou, et al. 2019. “Genetic LAMP2 Deficiency Accelerates the Age-Associated Formation of Basal Laminar Deposits in the Retina”. Proc Natl Acad Sci U S A 116 (47): 23724-34.

Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry

Publication: Journal Article

Consortium, Genetics Glaucoma People African Descent (GGLAD), Michael Hauser, Rand Allingham, Tin Aung, Carly Van Der Heide, Kent Taylor, Jerome Rotter, et al. 2019. “Association of Genetic Variants With Primary Open-Angle Glaucoma Among Individuals With African Ancestry”. JAMA 322 (17): 1682-91.

Lack of Correlation between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients

Publication: Journal Article

Stanwyck, Lynn, Kareem Moussa, Weilin Chan, Phil Aitken, and Lucia Sobrin. 2019. “Lack of Correlation Between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients”. Ophthalmol Retina 3 (11): 1007-9.

Topical sustained drug delivery to the retina with a drug-eluting contact lens

Publication: Journal Article

Ross, Amy, Lokendrakumar Bengani, Rehka Tulsan, Daniel Maidana, Borja Salvador-Culla, Hidenaga Kobashi, Paraskevi Kolovou, et al. 2019. “Topical Sustained Drug Delivery to the Retina With a Drug-Eluting Contact Lens”. Biomaterials 217: 119285.

Effect of Primary Occlusion Therapy in Asymmetric, Bilateral Amblyopia

Publication: Journal Article

Shoshany, Talia, Suzanne Michalak, Steven Staffa, Ryan Chinn, Kaila Bishop, and David Hunter. 2020. “Effect of Primary Occlusion Therapy in Asymmetric, Bilateral Amblyopia”. Am J Ophthalmol 211: 87-93.

Gopalan Gnanaguru, PhD

Person: Instructor in Ophthalmology

Profiles: Harvard Catalyst Profile

Crystal Sin Yi Cheung, MD

Person: Former Instructor in Ophthalmology

Message from the Editor-in-Chief

Page

Dear Colleagues, In this issue of eye Insights, we highlight two treatments for the management of strabismus: botulinum toxin and adjustable sutures. We include indications for their use, techniques to incorporate them into practice, and outcomes. A list of peer-reviewed journal articles is included...

Treatment Option: Botulinum Toxin

Page

Botulinum toxin (BT) for the management of strabismus was approved by the FDA in 1989 based on work by pediatric ophthalmologist Alan B. Scott, MD. BT can be the first-line treatment for certain forms of strabismus. Indications Acute comitant esotropia in children: BT can be injected to both medial...

Treatment Option: Adjustable Sutures

Page

Standard strabismus surgery involves altering the position or length of the extraocular muscles to improve ocular alignment. The muscle is reattached to the globe at a set position. The adjustable suture technique was introduced to refine the result immediately after surgery in both adults and...